AInvest★★★★★3-DAY FREE
Catch pre-market movers with AI signals.
Claim Trial
NOTV(Quitar la ciudad)
Inotiv·NASDAQ
--
--(--)
Signals Analysis
Bullish signal 0
Bearish signal 1
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About NOTV
Inotiv, Inc.
A leading contract research organization that provides contract-based bioanalytical, preclinical research services to pharmaceutical and drug development company
2701 Kent Avenue, West Lafayette, Indiana 47906
Provides nonclinical and analytical drug discovery and development services.
Inotiv, Inc., was founded in 1974 and began operating as Bioanalytical Systems, Inc., in 1975. In March 2021, the company changed its name to Inotiv, Inc., headquartered in West Lafayette, Indiana. Inotiv, Inc., is an international contract research organization providing drug discovery and development services. The company's customers and partners include pharmaceutical, biotechnology, academic and government agencies, etc. The company utilizes innovative technologies and products, as well as its commitment to quality, to help customers and partners accelerate the development of safe and effective therapies and maximize the return on investment in their research and development. The company offers an efficient variable cost plan to replace its customers' internal product development plans. The Company outsources development work to reduce overhead through U.S. Food and Drug Administration (" FDA ") approval. The company generates revenue from selling its research services and drug development tools, both of which focus on determining the safety and efficacy of drugs.
Company Financials
EPS
NOTV has released its 2026 Q2 earnings. EPS was reported at -0.94, versus the expected -0.64, missing expectations. The chart below visualizes how NOTV has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
NOTV has released its 2026 Q2 earnings report, with revenue of 117.65M, reflecting a YoY change of -5.37%, and net profit of -32.47M, showing a YoY change of -118.40%. The Sankey diagram below clearly presents NOTV's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
No Data
You can ask Aime
No Data
